Wednesday, September 22, 2010

Who can you meet at Cell Based Assays & Bioanalytical Method Development 2010?

Over the past 5 years, the Cell Based Assays and Bioanalytical Method Development Conference has been the only place to learn from the scientists at the forefront of new approaches and solutions to the assay development obstacles you face everyday.

This year, hear the latest regulatory requirements, white paper authors and most recent case studies on new approaches to troubleshooting bioassay and bioanalytical challenges.

These companies will be there, will yours?

AAI Pharma Inc. * Alder BioPharmaceuticals * Allergan Inc. * Amgen Inc. * Biogen Idec * Bristol Myers Squibb * CBER FDA * Center for Molecular Medicine & Immunology * Cephalon Australia Pty Ltd * Charles River Laboratories * Facet Biotech * Food & Drug Administration * Genentech Inc. * Gregory Maschek * Human Genome Sciences Inc. * ImClone Systems * Immunogen Inc. * IRX Therapeutics * KaloBios * Laboratory of Cellular & Gene Therapy * Macrogenics Inc. * MedImmune Inc. * Pfizer * PPD Inc. * Process Confidence * Promega Corporation * Roche Diagnostics GmbH * SafeBridge Consultants Inc. * Sanofi Pasteur * Shire Human Genetic Therapies * TOLERX * Trion Pharma GmbH * University of Louisville James Graham Brown Cancer * US Pharmacopeia * Willem Oosterveen * Wyeth Pharmaceuticals

Share this article with your social network, just click below to share now!

No comments :

Post a Comment